SUTRO BIOPHARMA, INC. (STRO) Reports Material Event to SEC

SUTRO BIOPHARMA, INC. (NASDAQ:STRO) filed a Form 8-K with the Securities and Exchange Commission on February 10, 2026, disclosing a material event.

SUTRO BIOPHARMA, INC.'s stock currently trades at $15.64 with a market capitalization of $83.5M. The Healthcare company's stock moved following the disclosure.